DaVita Inc (DVA)
137.46
-0.48
(-0.35%)
USD |
NYSE |
May 10, 16:00
137.46
0.00 (0.00%)
After-Hours: 19:23
DaVita Enterprise Value: 22.58B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 22.58B |
| May 08, 2024 | 22.40B |
| May 07, 2024 | 22.56B |
| May 06, 2024 | 22.49B |
| May 03, 2024 | 22.27B |
| May 02, 2024 | 22.96B |
| May 01, 2024 | 22.74B |
| April 30, 2024 | 22.67B |
| April 29, 2024 | 22.60B |
| April 26, 2024 | 22.19B |
| April 25, 2024 | 22.13B |
| April 24, 2024 | 22.12B |
| April 23, 2024 | 22.23B |
| April 22, 2024 | 22.10B |
| April 19, 2024 | 21.69B |
| April 18, 2024 | 21.54B |
| April 17, 2024 | 21.68B |
| April 16, 2024 | 21.86B |
| April 15, 2024 | 21.88B |
| April 12, 2024 | 21.92B |
| April 11, 2024 | 22.01B |
| April 10, 2024 | 22.06B |
| April 09, 2024 | 22.24B |
| April 08, 2024 | 22.21B |
| April 05, 2024 | 22.20B |
| Date | Value |
|---|---|
| April 04, 2024 | 22.14B |
| April 03, 2024 | 22.35B |
| April 02, 2024 | 22.33B |
| April 01, 2024 | 22.57B |
| March 31, 2024 | 22.59B |
| March 28, 2024 | 21.74B |
| March 27, 2024 | 21.64B |
| March 26, 2024 | 21.50B |
| March 25, 2024 | 21.45B |
| March 22, 2024 | 21.40B |
| March 21, 2024 | 21.58B |
| March 20, 2024 | 21.81B |
| March 19, 2024 | 21.77B |
| March 18, 2024 | 21.65B |
| March 15, 2024 | 21.62B |
| March 14, 2024 | 21.56B |
| March 13, 2024 | 21.76B |
| March 12, 2024 | 21.84B |
| March 11, 2024 | 21.55B |
| March 08, 2024 | 21.49B |
| March 07, 2024 | 21.39B |
| March 06, 2024 | 21.21B |
| March 05, 2024 | 21.44B |
| March 04, 2024 | 20.67B |
| March 01, 2024 | 20.77B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
15.39B
Minimum
Aug 27 2019
23.53B
Maximum
Aug 04 2021
19.25B
Average
18.93B
Median
Enterprise Value Benchmarks
| Encompass Health Corp | 11.93B |
| HCA Healthcare Inc | 126.10B |
| Cardinal Health Inc | 26.02B |
| Stryker Corp | 136.50B |
| Chemed Corp | 8.347B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 239.65M |
| Revenue (Quarterly) | 3.071B |
| Total Expenses (Quarterly) | 2.629B |
| EPS Diluted (Quarterly) | 2.65 |
| Gross Profit Margin (Quarterly) | 32.29% |
| Profit Margin (Quarterly) | 7.80% |
| Earnings Yield | 6.40% |
| Operating Earnings Yield | 13.64% |
| Normalized Earnings Yield | 6.384 |